The Journal of Practical Medicine ›› 2026, Vol. 42 ›› Issue (11): 1973-1980.doi: 10.3969/j.issn.1006-5725.2026.11.011
• Chronic Disease Control • Previous Articles
Fang LI1,Xiaojuan ZHANG2,Wenli YANG2,Wen ZHONG2(
)
Received:2026-01-20
Online:2026-06-10
Published:2026-06-15
Contact:
Wen ZHONG
E-mail:261084201@qq.com
CLC Number:
Fang LI,Xiaojuan ZHANG,Wenli YANG,Wen ZHONG. The relationship between SII, CAR, CALLY index and acute attack of gouty arthritis[J]. The Journal of Practical Medicine, 2026, 42(11): 1973-1980.
Tab.1
Comparison of general data among the three groups"
| 资料 | GA急性期组(n = 63) | GA缓解期组(n = 62) | 健康对照组(n = 62) | t/F/χ2值 | P值 |
|---|---|---|---|---|---|
| 性别/例 | 0.117 | 0.943 | |||
| 男 | 56 | 55 | 54 | ||
| 女 | 7 | 7 | 8 | ||
| 年龄/岁 | 49.21 ± 13.17 | 50.16 ± 12.84 | 50.03 ± 11.55 | 0.106 | 0.900 |
| BMI/(kg/m2) | 25.83 ± 2.61 | 25.39 ± 2.58 | 26.02 ± 3.03 | 0.859 | 0.425 |
| 饮酒史/例 | 0.489 | 0.783 | |||
| 否 | 35 | 37 | 38 | ||
| 是 | 28 | 25 | 24 | ||
| 多关节受累/例 | 9.615 | 0.002 | |||
| 否 | 32 | 48 | - | ||
| 是 | 31 | 14 | - | ||
| 病程/年 | 5.23 ± 1.84 | 5.46 ± 1.79 | - | 0.708 | 0.480 |
| VAS评分/分 | 7.32 ± 1.56 | - | - | - | - |
| 合并高血压/例 | 1.272 | 0.529 | |||
| 否 | 42 | 44 | 47 | ||
| 是 | 21 | 18 | 15 | ||
| 合并糖尿病/例 | 0.525 | 0.769 | |||
| 否 | 52 | 53 | 54 | ||
| 是 | 11 | 9 | 8 | ||
| 规律降尿酸治疗/例 | 10.295 | 0.001 | |||
| 否 | 48 | 30 | - | ||
| 是 | 15 | 32 | - | ||
| 血尿酸/(μmol/L) | 519.88 ± 78.46 | 491.26 ± 70.55 | 313.09 ± 52.63 | 168.315 | < 0.001 |
| 血清肌酐/(μmol/L) | 88.49 ± 15.22 | 85.90 ± 12.30 | 72.26 ± 10.19 | 29.104 | < 0.001 |
| 总胆固醇/(mmol/L) | 4.81 ± 0.88 | 4.73 ± 0.91 | 4.65 ± 0.77 | 0.546 | 0.580 |
| 甘油三酯/(mmol/L) | 1.97 ± 0.57 | 1.88 ± 0.50 | 1.81 ± 0.43 | 1.586 | 0.208 |
Tab.2
Comparison of SII, CAR and CALLY index among the three groups"
| 组别 | SII指数/(×109/L) | CAR比值/(mg/g) | CALLY指数/[×109·g/(mg·L)] |
|---|---|---|---|
| GA急性期组(n = 63) | 865.31 ± 175.06 | 1.40 ± 0.44 | 1.85 ± 0.51 |
| GA缓解期组(n = 62) | 393.74 ± 94.92 | 0.22 ± 0.07 | 8.61 ± 1.71 |
| 健康对照组(n = 62) | 309.42 ± 80.29 | 0.08 ± 0.02 | 12.73 ± 2.60 |
| F值 | 363.928 | 491.714 | 572.448 |
| P值 | < 0.001 | < 0.001 | < 0.001 |
Tab.4
Logistic regression analysis on influencing factors of acute attack in patients with gout"
| 因素 | β | SE | Waldχ2值 | P值 | OR | 95%CI |
|---|---|---|---|---|---|---|
| 多关节受累 | 1.427 | 0.515 | 7.678 | 0.006 | 4.166 | 1.518 ~ 11.432 |
| 接受规律降尿酸治疗 | -1.056 | 0.357 | 8.750 | 0.003 | 0.348 | 0.173 ~ 0.700 |
| 血尿酸 | 0.004 | 0.003 | 1.778 | 0.186 | 1.004 | 0.998 ~ 1.010 |
| 血清肌酐 | 0.011 | 0.008 | 1.891 | 0.170 | 1.011 | 0.995 ~ 1.027 |
| 外周血SII指数 | 0.019 | 0.005 | 14.440 | < 0.001 | 1.019 | 1.009 ~ 1.029 |
| 外周血CAR比值 | 3.208 | 0.823 | 15.194 | < 0.001 | 24.730 | 4.928 ~ 124.099 |
| 外周血CALLY指数 | -2.149 | 0.565 | 14.467 | < 0.001 | 0.117 | 0.039 ~ 0.353 |
Tab.6
Changes of SII, CAR and CALLY index before and after treatment in patients with GA during acute stage"
| 时间 | SII指数/(× 109/L) | CAR比值/(mg/g) | CALLY指数/[× 109·g/(mg·L)] |
|---|---|---|---|
| 治疗前(n = 63) | 865.31 ± 175.06 | 1.40 ± 0.44 | 1.85 ± 0.51 |
| 治疗后(n = 63) | 419.73 ± 82.29 | 0.38 ± 0.11 | 7.13 ± 1.02 |
| t值 | 27.485 | 29.440 | 36.692 |
| P值 | < 0.001 | < 0.001 | < 0.001 |
Tab.7
Multivariate linear regression analysis on influencing factors of ΔVAS"
| 因素 | β | SE | Waldχ2值 | P值 | OR | 95%CI |
|---|---|---|---|---|---|---|
| 年龄 | -0.008 | 0.012 | 0.444 | 0.505 | 0.992 | 0.969 ~ 1.016 |
| 基线VAS评分 | 0.105 | 0.071 | 2.187 | 0.140 | 1.111 | 0.966 ~ 1.277 |
| Δ%SII | 0.097 | 0.032 | 9.188 | 0.003 | 1.102 | 1.035 ~ 1.173 |
| Δ%CAR | 0.062 | 0.019 | 10.648 | 0.001 | 1.064 | 1.025 ~ 1.104 |
| Δ%CALLY指数 | 0.144 | 0.023 | 39.198 | < 0.001 | 1.155 | 1.104 ~ 1.208 |
| [1] |
LI D, YUE X, WANG A, et al. Relieving urinary tract obstructions may increase the risk of gouty arthritis in patients with hyperuricemia and postrenal obstructions[J]. Medicine (Baltimore),2024,103(2):e36911.doi:10.1097/MD. 0000000000036911 .
doi: 10.1097/MD. 0000000000036911 |
| [2] |
TIAN J, LIU Y, GAO W, et al. NETs activate AIM2 to mediate synovial fibroblast pyroptosis and promote acute gouty arthritis development[J]. Immunol Lett,2025,275(6):107007.doi:10.1016/j.imlet.2025.107007 .
doi: 10.1016/j.imlet.2025.107007 |
| [3] |
LIN S K, CHEN S T, ZHAN Y, et al. The alleviatory effects of koumine on MSU-induced gouty arthritis via the TLR4/NF-κB/NLRP3 pathway[J]. Basic Clin Pharmacol Toxicol,2024,135(2):133-147.doi:10.1111/bcpt.14037 .
doi: 10.1111/bcpt.14037 |
| [4] |
LI H N, LIU J, SHAO Z, et al. Gouty arthritis patients' diagnostic, biochemical, and hematological characteristics study: A single-center retrospective study[J]. BMC Musculoskelet Disord,2024,25(1):1054.doi:10.1186/s12891-024-06644-1 .
doi: 10.1186/s12891-024-06644-1 |
| [5] |
ZHAO H, WU J, WU Q, et al. Systemic immune-inflammation index values are associated with non-melanoma skin cancers: Evidence from the National Health and Nutrition Examination Survey 2010-2018[J]. Arch Med Sci,2024,20(4):1128-1137.doi:10.5114/aoms.2024.129343 .
doi: 10.5114/aoms.2024.129343 |
| [6] |
QU P, DU S, WANG W, et al. Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking[J]. Medicine (Baltimore),2024,103(1):e36722.doi:10.1097/MD. 0000000000036722 .
doi: 10.1097/MD. 0000000000036722 |
| [7] |
JI H, LUO Z, YE L, et al. Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction[J]. Int Immunopharmacol,2024,141(15):112860.doi:10.1016/j.intimp.2024.112860 .
doi: 10.1016/j.intimp.2024.112860 |
| [8] |
LIANG L, SU Q. Systemic immune-inflammation index and the short-term mortality of patients with sepsis: A meta-analysis[J]. Biomol Biomed,2025,25(4):798-809.doi:10.1186/s40246-025-00792-9 .
doi: 10.1186/s40246-025-00792-9 |
| [9] |
郭昊欣,吴文博,薛文飞,等. 全身免疫炎症指数联合C反应蛋白/白蛋白对非小细胞肺癌的预后价值[J]. 中国免疫学杂志,2025,41(7):1605-1609.doi:10.13431/j.cnki.immunol.j. 20250089 .
doi: 10.13431/j.cnki.immunol.j. 20250089 |
| [10] |
CHEN X, LI A, MA Q. Neutrophil-lymphocyte ratio and systemic immune-inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: A population-based study[J]. Inflammopharmacology,2024,32(5):3213-3227.doi:10.1007/s10787-024-01289-4 .
doi: 10.1007/s10787-024-01289-4 |
| [11] |
NEOGI T, JANSEN T L, DALBETH N,et al. 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheumatol,2015,67(10):2557-2568.doi:10.1002/art.39584 .
doi: 10.1002/art.39584 |
| [12] |
SCHLESINGER N, PILLINGER M H, LIPSKY P E. Knowledge of and stated adherence to the 2020 American college of rheumatology guideline for gout management: Results of a survey of US rheumatologists[J]. J Rheumatol,2025,52(1):77-86.doi: 10.3899/jrheum.2023-0981 .
doi: 10.3899/jrheum.2023-0981 |
| [13] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志, 2020, 36(1): 1-13.doi:10.3760/cma.j.issn.1000-6699.2020.01.001 .
doi: 10.3760/cma.j.issn.1000-6699.2020.01.001 |
| [14] |
HU B, YANG X R, XU Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res,2014,20(23):6212-6222.doi:10.1158/1078-0432.CCR-14-0442 .
doi: 10.1158/1078-0432.CCR-14-0442 |
| [15] |
RANZANI O T, ZAMPIERI F G, FORTE D N, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients[J]. PLoS One,2013,8(3):e59321.doi:10.1371/journal.pone. 0059321 .
doi: 10.1371/journal.pone. 0059321 |
| [16] |
Muller L, Hahn F, Mahringer-Kunz A, et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: Evaluation of the CALLY index[J]. Cancers (Basel), 2021,13(19):5018.doi:10.3390/cancers13195018 .
doi: 10.3390/cancers13195018 |
| [17] |
SCOTT J, HUSKISSON E C. Graphic representation of pain[J]. Pain, 1976,2(2):175-184.doi:10.1016/0304-3959(76)90044-8 .
doi: 10.1016/0304-3959(76)90044-8 |
| [18] |
朱晓霞,鲁健,施亚男.基于超声影像组学对痛风性关节炎急性发作的预测及与炎症因子水平的关系[J].影像科学与光化学,2024,42(5):459-470.doi:10.11944/j.issn.1000-3630. 2024.05.008 .
doi: 10.11944/j.issn.1000-3630. 2024.05.008 |
| [19] |
ZHAO X, LI M, LU Y, et al. Sirt1 inhibits macrophage polarization and inflammation in gouty arthritis by inhibiting the MAPK/NF-κB/AP-1 pathway and activating the Nrf2/HO-1 pathway[J]. Inflamm Res, 2024,73(7):1173-1184.doi:10.1007/s00011-024-01764-1 .
doi: 10.1007/s00011-024-01764-1 |
| [20] |
BORGHINI A, MERCURI A, ANDREASSI M G. Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios, and systemic immune-inflammation index as predictors of mortality in coronary artery disease[J]. J Cardiovasc Transl Res,2023,16(2):473-475.doi:10.1007/s12265-023-10186-5 .
doi: 10.1007/s12265-023-10186-5 |
| [21] |
WU Y, HUANG Y, SUN J, et al. Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis[J]. Front Immunol, 2025,16(7):1621209.doi:10.3389/fimmu.2025.1621209 .
doi: 10.3389/fimmu.2025.1621209 |
| [22] |
JIANG Y, TU X, LIAO X, et al. New inflammatory marker associated with disease activity in gouty arthritis: The systemic inflammatory response index[J]. J Inflamm Res,2023,24(16):5565-5573.doi:10.2147/JIR.S416644 .
doi: 10.2147/JIR.S416644 |
| [23] |
HU B, YANG XR, XU Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res,2014,20(23):6212-6222.doi:10.1158/1078-0432.CCR-14-1288 .
doi: 10.1158/1078-0432.CCR-14-1288 |
| [24] |
ZHAO X, FAN Y, SUN J, et al. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials[J]. Int Immunopharmacol,2025,149(6):114223.doi:10.1016/j.intimp.2025.114223 .
doi: 10.1016/j.intimp.2025.114223 |
| [25] |
SHU C, YANG F, ZHU F, et al. Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis[J]. Eur J Med Res,2022,27(1):245.doi:10.1186/s40001-022-01286-4 .
doi: 10.1186/s40001-022-01286-4 |
| [26] |
LI W, DENG F. Clinical significance of measuring MP-DNA, C-reactive protein, and inflammatory cytokines in children with mycoplasma pneumoniae pneumonia[J]. Am J Transl Res, 2024,16(2):577-583.doi:10.1155/2024/7928136 .
doi: 10.1155/2024/7928136 |
| [27] |
TAKEDA Y, SUGANO H, OKAMOTO A, et al. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery[J]. Asian J Surg, 2024,47(8):3492-3498.doi:10.1016/j.asjsur.2024.03.030 .
doi: 10.1016/j.asjsur.2024.03.030 |
| [28] |
WU T, ZHAO X, TU C, et al. Association between the C-reactive protein-albumin-lymphocyte index and severity of acute coronary syndrome: A retrospective study[J]. J Int Med Res,2025,53(10):1579-1582.doi: 10.1177/03000605251381579 .
doi: 10.1177/03000605251381579 |
| [29] |
SILVA G A D, OLIVEIRA L C, WIEGERT E V M, et al. Prognostic risk stratification using C-reactive protein, albumin, and associated inflammatory biomarkers in patients with advanced cancer in palliative care[J]. Curr Probl Cancer,2024,51(10):101115.doi:10.1016/j.currproblcancer.2024.101115 .
doi: 10.1016/j.currproblcancer.2024.101115 |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||

